Apricus Biosciences Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Apricus Biosciences

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: mokelumne river who wrote (1811)	4/2/2016 11:59:01 AM
From: Strong Long	of 2026

James thank you for your response. I suppose the mention of Vitaros US approval alone - as one of the pathways towards profitability in 2017 - could lead to that in fact (profitability). I sure would like to get my hands on some Vitaros myself just to see how effective and easy it is to use. I really don't know why the market does not value it, if it is in fact effective and not too difficult to use...granted US approval would be huge and might very well change that sentiment. The Denner position at this point is very intriguing. I am curious to see what his next move is. MI thanks for your thoughts on Vitaros FDA approval. That's what I was getting at...it was a question mark. I was not sure if the manufacturing batch issues would factor in to the approval process or not?

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next